"Melflufen plus dexamethasone in relapsed and refractory multiple myelo" by Claudia Paba Prada

Menu

Skip to main content

All Publications

Claudia Paba Prada, Miami Cancer InstituteFollow

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study

Publication Date

2020

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Lancet Haematol (2020) 7(5):e395-e407

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS